HHS seeks feedback 340B rebate model redesign after court rulings halted the pilot, inviting stakeholder input through March 19.

The American Academy of Ophthalmology has asked CMS and HHS to prohibit health insurers from recommending biosimilars as alternative treatments for eye disease. The request comes in the wake of a ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo (Reuters) -The U.S. Department ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Biosimilars is a biologic medication that is highly similar to an ...

Biologic therapies, such as monoclonal antibodies and colony-stimulating factors, have an important role in modern medical practice, but also create challenges due to their relatively high cost. Using ...

The U.S. FDA on Wednesday issued draft guidance that aims to accelerate the process for getting biosimilar drugs -- essentially generic versions of pricey biologic-based medicines -- to consumers. The ...